FIGURE 1.
FIGURE 1.
Representative cortical 18F-FDG PET patterns in NL, AD, DLB, and FTD. 3D-SSP maps and corresponding Z scores showing CMRglc reductions in clinical groups as compared with the NL database are displayed on a color-coded scale ranging from 0 (black) to 10 (red). From left to right: 3D-SSP maps are shown on the right and left lateral, superior and inferior, anterior and posterior, and right and left middle views of a standardized brain image.
In this issue
Related Articles
Cited By...
- Fast Interneuron Dysfunction in Laminar Neural Mass Model Reproduces Alzheimers Oscillatory Biomarkers
- BOLD Amplitude Correlates of Preclinical Alzheimers Disease
- SNMMI Procedure Standard/EANM Practice Guideline for Brain [18F]FDG PET Imaging, Version 2.0
- Early brain neuroinflammatory and metabolic changes identified by dual tracer microPET imaging in mice with acute liver injury
- Personalized modeling of neurodegeneration determines dementia severity from EEG recordings
- Brain Trauma Imaging
- Model-based whole-brain perturbational landscape of neurodegenerative diseases
- In Situ Microwave Fixation to Define the Terminal Rodent Brain Metabolome
- Brain Metabolism Related to Mild Cognitive Impairment and Phenoconversion in Patients With Isolated REM Sleep Behavior Disorder
- Cerebral hypoperfusion is a late pathological event in the course of Alzheimers disease
- Donor-Specific Transcriptomic Analysis of Alzheimer's Disease-Associated Hypometabolism Highlights a Unique Donor, Ribosomal Proteins and Microglia
- APOE4 Lowers Energy Expenditure and Impairs Glucose Oxidation by Increasing Flux through Aerobic Glycolysis
- Longitudinal structural and metabolic changes in frontotemporal dementia
- Donor specific transcriptomic analysis of Alzheimers disease associated hypometabolism highlights a unique donor, microglia, and ribosomal proteins
- Limits for Reduction of Acquisition Time and Administered Activity in 18F-FDG PET Studies of Alzheimer Dementia and Frontotemporal Dementia
- Neural correlates of exceptional memory ability in SuperAgers: A multimodal approach using FDG-PET, PIB-PET, and MRI
- An evidence-based algorithm for the utility of FDG-PET for diagnosing Alzheimer's disease according to presence of medial temporal lobe atrophy
- Motion discrimination in dementia with Lewy bodies and Alzheimer disease
- Automated Quantification of 18F-Flutemetamol PET Activity for Categorizing Scans as Negative or Positive for Brain Amyloid: Concordance with Visual Image Reads
- Complementary Role of 18F-FDG PET and 123I-Ioflupane SPECT in the Diagnosis of Lewy Body Disease
- Systematic Comparison of the Performance of Integrated Whole-Body PET/MR Imaging to Conventional PET/CT for 18F-FDG Brain Imaging in Patients Examined for Suspected Dementia
- [18F]FDG-PET is superior to [123I]IBZM-SPECT for the differential diagnosis of parkinsonism
- Nuclear medicine functional imaging of the brain
- Inclusion criteria provide heterogeneity in baseline profiles of patients with mild cognitive impairment: comparison of two prospective cohort studies
- Brain Imaging in Alzheimer Disease
- Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature
- Target-Specific PET Probes for Neurodegenerative Disorders Related to Dementia
- Combining MR Imaging, Positron-Emission Tomography, and CSF Biomarkers in the Diagnosis and Prognosis of Alzheimer Disease